Despite women making up half of the world's population, an increasingly smaller sum of the many billions of dollars spent on the research and development of new drugs goes to diseases related specifically to women.
This paradox is now being highlighted by Bioinnovation Institute (BII), which supports early-stage life science start-ups from its headquarters in biotech hub COBIS, located in Copenhagen. The company is now seeking to correct this incongruity by aiding the area.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.